A group of top SA medical specialists has called on the SA Health Products Regulatory Authority (Sahpra) to lift the pause on administering the J&J Covid-19 vaccine immediately, citing research published this week that explains the rarity of the blood clotting condition that has caused concerns about its safety.

Prof Barry Jacobson, who is the president of the SA Society of Thrombosis and Haemostasis, says that two reports published in the US’s New England Journal of Medicine indicate that the condition is so rare, it is as likely to get it as to be struck by lightning twice...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now